1 - 25 of 1
Number of results to display per page
TitleCreatorDescriptionIdentifier
1 Natalizumab Reduces Loss of Visual Function in Patients with Relapsing Multiple SclerosisBalcer, Laura J; Galetta, Steven L; O'Connor, Paul W; Hardova, E; Hutchinson, Michael; Kappos, Ludwig; Miller, David H; Phillips, J Theodore; Polman, Chris H; Stuart, William H; Calabresi, Peter; Confavreux, Christian; Radue, Ernst W; Rudick, Richard A; Lublin, Fred D; Giovannoni, Gavin; Wajgt, Andr...Although visual dysfunction is one of the most common causes of disability in patients with multiple sclerosis (MS), the quantitative assessment of vision in MS clinical trials has been traditionally limited to non-standardized measures of Snellen acuity. As such, the effects MS therapies on visual ...20060301_nanos_sciplatform_07.pdf
1 - 25 of 1